Advertisement

Topics

ORIX Leveraged Finance Company Profile

08:28 EST 16th December 2018 | BioPortfolio

ORIX Leveraged Finance, a business unit of ORIX USA Corporation, is a capital solutions provider focused on senior debt facilities and equity co-investments in well-managed small and mid-sized businesses in all industry sectors throughout the United States. For more information about ORIX Leveraged Finance, visit www.orixleveragedfinance.com. ORIX USA Corporation is a Dallas-based financial conglomerate with more than 1,400 employees and primary offices in Dallas, New York, Los Angeles, Columbus and Minneapolis. ORIX USA holds approximately $6 billion of assets and manages an additional $25 billion. ORIX USA is a wholly owned subsidiary of ORIX Corporation, a Tokyo-based, publicly owned international financial services company with operations in 28 countries worldwide. ORIX Corporation is listed on the Tokyo (8591) and New York Stock Exchanges (IX). For more information on ORIX USA, visit www.orix.com.


News Articles [268 Associated News Articles listed on BioPortfolio]

Vinson Elkins Bolsters Global Leveraged Finance Practice with Addition of Noel Hughes in London

LONDON, Sept. 10, 2018 /PRNewswire/ -- Vinson & Elkins announced today the addition of internationally recognized capital markets partner Noel Hughes to its global Leveraged Read more...

Horizon Pharma (HZNP) Presents At Bank of America Merrill Lynch Leveraged Finance Conference - Slideshow

Community Health Systems (CYH) Presents At Bank of America Merrill Lynch Leveraged Finance Conference - Slideshow

Community Health Systems to Participate in Bank of America Merrill Lynch 2018 Leveraged Finance Conference

Community Health Systems, Inc. (NYSE: CYH) today announced that management will participate in the Bank of America Merrill Lynch 2018 Leveraged Finance Conference to be held&...

Peter Zone joins White Oak Healthcare Finance to Deepen Leveraged Lending Expertise

White Oak Healthcare Finance, LLC (“White Oak”), an affiliate of White Oak Global Advisors, LLC, is pleased to announce that healthcare industry veteran Peter Zone has joined ...

Clinical Finance: The Most Precious Of The Necessary Evils

Clinical Informatics News | Clinical finance can sometimes be viewed as a necessary evil. Chris Chan, Executive Director, R&D Finance, at Fibrogen, discusses how clinical finance can improve ...

Endo to Participate at Bank of America Merrill Lynch Leveraged Finance Conference

DUBLIN, Nov. 28, 2018 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Bank of America Merrill Lynch Leve...

In Northern California, Leaders at One FQHC Leveraged Technology to Help a Community in Crisis

Heather LandiIn the midst of the October wildfires that ravaged Northern California communities, leaders at Petaluma Health Center leveraged technology tools to quickly communicate with patients and p...

Drugs and Medications [0 Results]

None

PubMed Articles [59 Associated PubMed Articles listed on BioPortfolio]

The dominance of finance in healthcare: political action of unlimited capital in the 21st century.

This article gives, first, a historical account of the action of capital in healthcare in contemporary Brazil and then introduces a debate on the dominance of finance ('financial dominance') in health...

Public-private partnerships in practice: collaborating to improve health finance policy in Ghana and Kenya.

The Economic Transition of Health in Africa: A Call for Progressive Pragmatism to Shape the Future of Health Financing.

Abstract-The new financing landscape for the Sustainable Development Goals has a larger emphasis on domestic resource mobilization. But, given the significant role of donor assistance for health, the ...

Can Ethiopia Finance the Continued Development of Its Primary Health Care System If External Resources Decline?

Ethiopia's recent improvements in health outcomes benefited from the large increase in development assistance for health received in recent years, most of which supported its primary care system. Incr...

The effect of 3-month finasteride challenge on biomarkers for predicting cancer outcome on biopsy: Results of a randomized trial.

Finasteride, a 5-alpha reductase inhibitor may have effects on biomarkers such as prostate-specific antigen (PSA) that could be leveraged to improve screening.

Clinical Trials [18 Associated Clinical Trials listed on BioPortfolio]

Effect of a Micro-finance-based Intervention for the Prevention of Intimate-partner Violence and HIV

The high rates of HIV infection in women have brought into sharp focus the problem of violence against women. There is a growing recognition that women and girls' risk of and vulnerability...

The Influence of Significant Weight Lost on the Quality of Voice

The rate of obesity and bariatric surgery is rising steadily. Though Bariatric Surgery Influences on aspects such as endocrin analysis, finance, etc are well tested, quantitative and quali...

Evaluating the Hunger Project in Ghana

The Hunger Project/Epicenter strategy is a community based development strategy that will positively affect health, education, empowerment, and consumption.

Soberlink - MAP Outcomes Study Protocol

The purpose of this study is to show the effectiveness of Soberlink's remote alcohol monitoring system integrated with MAP's patient engagement platform (EHR) to monitor a sample size of a...

Assessing the Preliminary Effects of a Multisectoral Agricultural Intervention on Adolescent Girls' Health

The goal of this study is to understand how the Shamba Maisha household agricultural and economic intervention impacts the sexual, reproductive, and nutritional health of adolescent girls....

Companies [437 Associated Companies listed on BioPortfolio]

ORIX Leveraged Finance

ORIX Leveraged Finance, a business unit of ORIX USA Corporation, is a capital solutions provider focused on senior debt facilities and equity co-investments in well-managed small ...

ORIX Venture Finance LLC

ORIX Venture Finance provides customized financial solutions up to $50 million in capital per transaction to mid- and late-stage companies which have established customers and run...

ORIX USA Asset Management

ORIX USA is a diversified financial company with more than $5 billion of assets in sectors spanning commercial finance, venture finance, commercial real estate, mortgage backed se...

ORIX Ventures

ORIX Ventures provides customized financial solutions up to $50 million in capital per transaction to mid- and late-stage companies which have established customers and run-rate r...

Brigade Capital Management, LP

Brigade Capital Management, LP is an SEC-registered investment advisor focusing on investing in the global high-yield market. The firm was founded by Donald E. Morgan, III and Pat...

More Information about "ORIX Leveraged Finance" on BioPortfolio

We have published hundreds of ORIX Leveraged Finance news stories on BioPortfolio along with dozens of ORIX Leveraged Finance Clinical Trials and PubMed Articles about ORIX Leveraged Finance for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ORIX Leveraged Finance Companies in our database. You can also find out about relevant ORIX Leveraged Finance Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record